| Literature DB >> 33997336 |
Anran Jiao1, Hui Diao1, Bing Yu1, Jun He1, Jie Yu1, Ping Zheng1, Yuheng Luo1, Junqiu Luo1, Quyuan Wang1, Huifen Wang1, Xiangbing Mao1, Daiwen Chen1.
Abstract
Short chain fatty acids (SCFA) are the main products of indigestible carbohydrates undergoing bacterial fermentation in the hindgut, which are related to some physiological functions. This study was designed to investigate the effects of SCFA infusion by ileum on the carcass traits, meat quality and lipid metabolism of growing pigs. In a 28-day study, 24 growing barrows fitted with a T-cannula in distal ileum were divided into 4 treatments: 1) Control, 2) antibiotics (AB), 3) AB + 300 mL of SCFA1 solution (ABS1), 4) AB + 300 mL of SCFA2 solution (ABS2). The concentrations of acetate, propionate and butyrate in SCFA1 solution were respectively 61.84, 18.62 and 12.55 mmol/L, and in SCFA2 were respectively 40.08, 15.41 and 9.78 mmol/L. The results showed that the SCFA infusion increased the average daily feed intake and average daily gain of pigs (P < 0.05). Meanwhile, the SCFA treatments increased longissimus dorsi area (P < 0.05) and carcass weight (P = 0.058), decreased the drip loss of longissimus dorsi (P = 0.059), and reduced serum concentrations of triglyceride, total cholesterol and urea nitrogen (P < 0.05). Besides, the SCFA administration inhibited the mRNA expressions of fatty acid synthase (FAS) and acetyl-CoA carboxylase in longissimus dorsi (P < 0.05), the mRNA expression of FAS in the liver (P < 0.05), and the mRNA expression of hormone-sensitive lipase in abdominal fat (P < 0.05). Short chain fatty acid infusion also enhanced the mRNA expression of carnitine palmitoyltransferase-1α in the liver (P < 0.05), the mRNA expressions of peroxisome proliferator activated receptor gamma and lipoprotein lipase in abdominal fat (P < 0.05), and the mRNA expressions of free fatty acid receptor 2, glucose-6-phosphatase and phosphoenolpyruvate carboxykinase 1 in the colon (P < 0.05). These results suggested that SCFA administration in the ileum could improve the carcass traits and meat quality of growing pigs, which was possibly due to the fact that SCFA modulated lipid metabolism.Entities:
Keywords: Carcass trait; Growing pig; Lipid metabolism; Meat quality; Short chain fatty acid
Year: 2020 PMID: 33997336 PMCID: PMC8110845 DOI: 10.1016/j.aninu.2020.05.009
Source DB: PubMed Journal: Anim Nutr ISSN: 2405-6383
Composition and nutrient levels of experimental diets (air-dry basis, %).
| Item | Content |
|---|---|
| Ingredients | |
| Corn | 78.20 |
| Soybean meal | 14.60 |
| Soybean oil | 1.00 |
| Fish meal | 4.50 |
| Limestone | 0.35 |
| Dicalcium phosphate | 0.27 |
| Salt | 0.25 |
| 78% Lys | 0.34 |
| | 0.10 |
| 98.5% Thr | 0.02 |
| 98% Trp | 0.07 |
| Chloride choline | 0.05 |
| Vitamin premix | 0.05 |
| Mineral premix | 0.20 |
| Total | 100.00 |
| Calculated composition | |
| DE, MJ/kg | 3.40 |
| CP | 15.74 |
| Ca | 0.52 |
| TP | 0.50 |
| AP | 0.32 |
| Lys | 0.98 |
| Met + Cys | 0.35 |
| Thr | 0.59 |
| Trp | 0.17 |
DE = digestible energy; TP = total phosphorus; AP = available phosphorus.
The premix provides the following per kilogram of diet: vitamin A 5,512 IU, vitamin D3 2,250 IU, vitamin E 24 mg, vitamin K3 3 mg, vitamin B2 6 mg, vitamin B6 3 mg, vitamin B12 24 μg, folic acid 1.2 mg, nicotinic acid 14 mg, biotin 150 μg, d-pantothenic acid 15 mg.
The premix provides the following per kilogram diet: Fe 60 mg, Cu 4 mg, Mn 2 mg, Zn 60 mg, I 0.14 mg, Se 0.2 mg.
Primers lists used for real-time quantitative PCR assay.
| Gene name | Primer | Sequence 5' – 3′ |
|---|---|---|
| β-actin | Sense | TCTGGCACCACACCTTCT |
| Antisense | TGATCTGGGTCATCTTCTCAC | |
| Sense | CTACGAGGCCATTGTGGACG | |
| Antisense | AGCCTATCATGCTGTAGCCC | |
| Sense | AGCAAGGTCGAGACCGAAAG | |
| Antisense | TAAGACCACCGGCGGATAGA | |
| Sense | CGACCTGGAAAGCCCGTTAT | |
| Antisense | GAGGCTTTGTCCCCACAGAT | |
| Sense | AAGCGGACGGCTCACAATG | |
| Antisense | GCAAGACGGCGGATTTATTCA | |
| Sense | CACATTCACCAGAGGGTC | |
| Antisense | TCATGGGAGCACTTCACG | |
| Sense | GACAAGTCCTTCACCCTCATCGC | |
| Antisense | GGGTTTGGTTTGCCCAGACAG | |
| Sense | GCCTTTCCTGCAGACCATCT | |
| Antisense | CACTGGTGAAGAGGGAGCTG | |
| Sense | TCAGCACGACTCCAGCCTTCA | |
| Antisense | GCTCAAGCAGTCTGGGCATTCT | |
| Sense | AAGCCAAGCGAAGGTGTGAGC | |
| Antisense | GGAACGGGAACCACTTGCTGAG | |
| Sense | AGATATGCTAATACACCGAT | |
| Antisense | CCAAACCCTTCTCAGATG | |
| Sense | CAAGAGGAACAAGAATAACAT | |
| Antisense | AAGAACTTACATCACTGGTA | |
| Sense | CGTGTTCATCGTTCAGTA | |
| Antisense | GAAGTTCTCATAGCAGGTA | |
| Sense | TGGAGACCTTACGTGTTG | |
| Antisense | CGAGGATGAGAAGTAGTAGAT |
FAS = fatty acid synthase; ACC = acetyl-CoA carboxylase; PPARγ = peroxisome proliferator activated receptor γ; SREBP-1c = sterol regulatory element binding protein 1c; LPL = lipoprotein lipase; CPT-1α = carnitine palmitoyltransferase-1α; HSL = hormone-sensitive lipase; PCK1 = phosphoenolpyruvate carboxy kinase 1; G6PC = glucose-6-phosphatase; PYY = peptide YY; GCG = glucagon; FFAR2 = free fatty acid receptor 2; FFAR3 = free fatty acid receptor 3.
Effects of SCFA on the growth performance of pigs over the experimental period.
| Item | Control | AB | ABS1 | ABS2 | SEM | |
|---|---|---|---|---|---|---|
| Initial BW, kg | 30.73 | 30.67 | 30.73 | 30.75 | 0.16 | 0.987 |
| Final BW, kg | 51.00b | 50.75b | 52.17ab | 53.92a | 0.71 | 0.026 |
| ADFI, kg | 1.46a | 1.42b | 1.46a | 1.45ab | 0.01 | 0.015 |
| ADG, kg | 0.72ab | 0.72b | 0.77ab | 0.83a | 0.03 | 0.036 |
| F:G ratio | 2.03 | 1.99 | 1.92 | 1.75 | 0.07 | 0.064 |
SCFA = short chain fatty acids; AB = antibiotics; ABS1 = AB + SCFA1; ABS2 = AB + SCFA2; BW = body weight; ADFI = average daily feed intake; ADG = average daily gain; F:G ratio = the ratio of feed to gain.
SCFA1, the concentrations of acetate, propionate and butyrate were 61.84, 18.62 and 12.55 mmol/L, respectively; SCFA2, the concentrations of acetate, propionate and butyrate were 40.08, 15.41 and 9.78 mmol/L, respectively.
a, b Within a row, means without a common superscript differ (P < 0.05).
Effects of SCFA on the carcass traits of pigs over the experimental period.
| Item | Control | AB | ABS1 | ABS2 | SEM | |
|---|---|---|---|---|---|---|
| Carcass weight, kg | 34.88 | 34.91 | 36.05 | 37.23 | 0.36 | 0.058 |
| Dressing percentage, % | 68.39 | 68.84 | 69.15 | 69.09 | 0.31 | 0.842 |
| Backfat thickness, cm | 1.35 | 1.35 | 1.49 | 1.36 | 0.04 | 0.457 |
| Abdominal fat weight, g | 169.33b | 216.00ab | 253.33a | 231.67a | 10.41 | 0.020 |
| Longissimus dorsi area, cm2 | 28.84bc | 26.75c | 31.78a | 30.27ab | 0.57 | 0.004 |
SCFA = short chain fatty acids; AB = antibiotics; ABS1 = AB + SCFA1; ABS2 = AB + SCFA2.
SCFA1, the concentrations of acetate, propionate and butyrate were 61.84, 18.62 and 12.55 mmol/L, respectively; SCFA2, the concentrations of acetate, propionate and butyrate were 40.08, 15.41 and 9.78 mmol/L, respectively.
a-c Within a row, means without a common superscript differ (P < 0.05).
Effects of SCFA on the meat quality of pigs over the experimental period.
| Item | Control | AB | ABS1 | ABS2 | SEM | |
|---|---|---|---|---|---|---|
| Drip loss, % | 1.76 | 1.86 | 1.31 | 1.46 | 0.09 | 0.059 |
| Cooking loss, % | 30.03 | 29.89 | 30.28 | 29.60 | 0.32 | 0.908 |
| Shear force, N | 33.28 | 32.99 | 28.20 | 30.04 | 1.50 | 0.604 |
| IMF, % | 2.36 | 2.98 | 2.61 | 2.42 | 0.12 | 0.296 |
| pH45 min | 7.03 | 6.97 | 7.06 | 6.95 | 0.05 | 0.867 |
| pH24 h | 5.36 | 5.33 | 5.42 | 5.43 | 0.02 | 0.166 |
| L∗45 min | 42.11b | 44.99a | 43.24ab | 44.52a | 0.38 | 0.020 |
| a∗45 min | 3.21 | 2.91 | 3.16 | 3.45 | 0.16 | 0.716 |
| b∗45 min | 2.60b | 3.60a | 3.47a | 4.00a | 0.16 | 0.012 |
| L∗24 h | 49.96a | 48.54ab | 45.42b | 45.78b | 0.66 | 0.028 |
| a∗24 h | 5.83 | 5.01 | 4.46 | 5.22 | 0.29 | 0.445 |
| b∗24 h | 5.80 | 5.56 | 4.42 | 4.80 | 0.30 | 0.337 |
SCFA = short chain fatty acids; AB = antibiotics; ABS1 = AB + SCFA1; ABS2 = AB + SCFA2; IMF = intramuscular fat.
SCFA1, the concentrations of acetate, propionate and butyrate were 61.84, 18.62 and 12.55 mmol/L, respectively; SCFA2, the concentrations of acetate, propionate and butyrate were 40.08, 15.41 and 9.78 mmol/L, respectively.
a, b Within a row, means without a common superscript differ (P < 0.05).
Effects of SCFA on the serum lipid-related metabolites and hormones of pigs over the experimental period.
| Item | Control | AB | ABS1 | ABS2 | SEM | |
|---|---|---|---|---|---|---|
| TG, mmol/L | 0.42b | 0.75a | 0.44b | 0.38b | 0.04 | 0.001 |
| TC, mmol/L | 3.48a | 4.20a | 2.34b | 1.99b | 0.24 | 0.010 |
| HDL-c, mmol/L | 2.42 | 2.25 | 1.89 | 1.52 | 0.18 | 0.288 |
| LDL-c, mmol/L | 0.69 | 0.82 | 0.81 | 0.84 | 0.05 | 0.665 |
| Urea nitrogen, mmol/L | 3.07a | 2.78ab | 2.30bc | 2.12c | 0.12 | 0.011 |
| Insulin, μIU/mL | 31.83 | 30.25 | 37.22 | 33.45 | 3.46 | 0.918 |
| Glucagon, μIU/mL | 435.96 | 318.26 | 288.86 | 132.21 | 50.13 | 0.199 |
| Leptin, ng/mL | 5.83 | 5.50 | 7.01 | 6.37 | 0.35 | 0.467 |
SCFA = short chain fatty acids; AB = antibiotics; ABS1 = AB + SCFA1; ABS2 = AB + SCFA2; TG = triglyceride; TC = total cholesterol; HDL-c = high density lipoprotein-cholesterol; LDL-c = low density lipoprotein-cholesterol.
SCFA1, the concentrations of acetate, propionate and butyrate were 61.84, 18.62 and 12.55 mmol/L, respectively; SCFA2, the concentrations of acetate, propionate and butyrate were 40.08, 15.41 and 9.78 mmol/L, respectively.
a-c Within a row, means without a common superscript differ (P < 0.05).
Effects of SCFA on the mRNA expressions for key factors related to lipid metabolism in longissimus dorsi of pigs over the experimental period.
| Item | Control | AB | ABS1 | ABS2 | SEM | |
|---|---|---|---|---|---|---|
| 1.00b | 1.78a | 0.97b | 0.83b | 0.12 | 0.010 | |
| 1.00b | 2.12a | 1.56ab | 1.23b | 0.15 | 0.029 | |
| 1.00 | 1.03 | 0.89 | 0.97 | 0.06 | 0.855 | |
| 1.00 | 1.08 | 0.90 | 0.69 | 0.08 | 0.383 | |
| 1.00 | 0.93 | 1.05 | 0.99 | 0.12 | 0.990 | |
| 1.00 | 0.67 | 1.21 | 0.95 | 0.13 | 0.555 | |
| 1.00 | 0.69 | 1.19 | 1.31 | 0.14 | 0.463 |
SCFA = short chain fatty acids; AB = antibiotics; ABS1 = AB + SCFA1; ABS2 = AB + SCFA2; FAS = fatty acid synthase; ACC = acetyl-CoA carboxylase; PPARγ = peroxisome proliferator-activated receptor-γ; SREBP-1c = sterol regulatory element binding protein 1c; HSL = hormone-sensitive lipase; LPL = lipoprotein lipase; CPT-1α = carnitine palmitoyltransferase-1α.
SCFA1, the concentrations of acetate, propionate and butyrate were 61.84, 18.62 and 12.55 mmol/L, respectively; SCFA2, the concentrations of acetate, propionate and butyrate were 40.08, 15.41 and 9.78 mmol/L, respectively.
a, b Within a row, means without a common superscript differ (P < 0.05).
Effects of SCFA on the mRNA expressions for key factors related to lipid metabolism in abdominal fat of pigs over the experimental period.
| Item | Control | AB | ABS1 | ABS2 | SEM | |
|---|---|---|---|---|---|---|
| 1.00 | 1.04 | 1.17 | 0.94 | 0.04 | 0.229 | |
| 1.00 | 1.06 | 1.07 | 1.05 | 0.02 | 0.712 | |
| 1.00a | 0.63b | 0.91a | 0.90a | 0.05 | 0.032 | |
| 1.00 | 1.05 | 1.16 | 1.08 | 0.04 | 0.537 | |
| 1.00b | 1.64a | 1.26b | 1.26b | 0.08 | 0.019 | |
| 1.00a | 0.65b | 0.99a | 1.03a | 0.05 | 0.004 | |
| 1.00 | 1.10 | 1.03 | 1.08 | 0.03 | 0.612 |
SCFA = short chain fatty acids; AB = antibiotics; ABS1 = AB + SCFA1; ABS2 = AB + SCFA2; FAS = fatty acid synthase; ACC = acetyl-CoA carboxylase; PPARγ = peroxisome proliferator-activated receptor-γ; SREBP-1c = sterol regulatory element binding protein 1c; HSL = hormone-sensitive lipase; LPL = lipoprotein lipase; CPT-1α = carnitine palmitoyltransferase-1α.
SCFA1, the concentrations of acetate, propionate and butyrate were 61.84, 18.62 and 12.55 mmol/L, respectively; SCFA2, the concentrations of acetate, propionate and butyrate were 40.08, 15.41 and 9.78 mmol/L, respectively.
a, b Within a row, means without a common superscript differ (P < 0.05).
Effects of SCFA on the mRNA expressions for key factors related to lipid metabolism in the liver of pigs over the experimental period.
| Item | Control | AB | ABS1 | ABS2 | SEM | |
|---|---|---|---|---|---|---|
| 1.00b | 1.70a | 1.03b | 1.10b | 0.09 | 0.011 | |
| 1.00 | 0.89 | 0.93 | 1.03 | 0.05 | 0.729 | |
| 1.00 | 1.01 | 0.91 | 1.15 | 0.05 | 0.389 | |
| 1.00 | 0.87 | 0.98 | 1.10 | 0.05 | 0.531 | |
| 1.00 | 1.08 | 1.07 | 1.16 | 0.05 | 0.680 | |
| 1.00 | 0.84 | 0.97 | 1.15 | 0.05 | 0.222 | |
| 1.00a | 0.64b | 0.92a | 0.90a | 0.05 | 0.032 |
SCFA = short chain fatty acids; AB = antibiotics; ABS1 = AB + SCFA1; ABS2 = AB + SCFA2; FAS = fatty acid synthase; ACC = acetyl-CoA carboxylase; PPARγ = peroxisome proliferator-activated receptor-γ; SREBP-1c = sterol regulatory element binding protein 1c; HSL = hormone-sensitive lipase; LPL = lipoprotein lipase; CPT-1α = carnitine palmitoyltransferase-1α.
SCFA1, the concentrations of acetate, propionate and butyrate were 61.84, 18.62 and 12.55 mmol/L, respectively; SCFA2, the concentrations of acetate, propionate and butyrate were 40.08, 15.41 and 9.78 mmol/L, respectively.
a, b Within a row, means without a common superscript differ (P < 0.05).
Effects of SCFA on the mRNA expressions for key factors in caecum of pigs over the experimental period.
| Item | Control | AB | ABS1 | ABS2 | SEM | |
|---|---|---|---|---|---|---|
| 1.00 | 1.10 | 0.93 | 0.99 | 0.03 | 0.260 | |
| 1.00 | 1.02 | 0.96 | 1.03 | 0.02 | 0.756 | |
| 1.00 | 1.01 | 0.99 | 1.16 | 0.03 | 0.305 | |
| 1.00 | 1.11 | 1.00 | 1.10 | 0.03 | 0.450 | |
| 1.00a | 0.68b | 1.03a | 1.08a | 0.06 | 0.038 | |
| 1.00a | 0.71b | 0.97a | 1.08a | 0.05 | 0.041 |
SCFA = short chain fatty acids; AB = antibiotics; ABS1 = AB + SCFA1; ABS2 = AB + SCFA2; G6PC = glucose-6-phosphatase; PCK1 = phosphoenolpyruvate carboxykinase 1; GCG = glucagon; PYY = peptide YY; FFAR2 = free fatty acid receptor 2; FFAR3 = free fatty acid receptor 3.
SCFA1, the concentrations of acetate, propionate and butyrate were 61.84, 18.62 and 12.55 mmol/L, respectively; SCFA2, the concentrations of acetate, propionate and butyrate were 40.08, 15.41 and 9.78 mmol/L, respectively.
a, b Within a row, means without a common superscript differ (P < 0.05).
Effects of SCFA on the mRNA expressions for key factors in the colon of pigs over the experimental period.
| Item | Control | AB | ABS1 | ABS2 | SEM | |
|---|---|---|---|---|---|---|
| 1.00a | 0.67b | 0.94a | 0.85ab | 0.04 | 0.012 | |
| 1.00a | 0.62b | 1.02a | 1.01a | 0.06 | 0.041 | |
| 1.00 | 1.05 | 1.12 | 1.02 | 0.03 | 0.390 | |
| 1.00 | 1.07 | 0.96 | 0.88 | 0.04 | 0.331 | |
| 1.00a | 0.71b | 1.01a | 1.05a | 0.05 | 0.035 | |
| 1.00 | 1.08 | 0.97 | 1.02 | 0.02 | 0.426 |
SCFA = short chain fatty acids; AB = antibiotics; ABS1 = AB + SCFA1; ABS2 = AB + SCFA2; G6PC = glucose-6-phosphatase; PCK1 = phosphoenolpyruvate carboxykinase 1; GCG = glucagon; PYY = peptide YY; FFAR2 = free fatty acid receptor 2; FFAR3 = free fatty acid receptor 3.
SCFA1, the concentrations of acetate, propionate and butyrate were 61.84, 18.62 and 12.55 mmol/L, respectively; SCFA2, the concentrations of acetate, propionate and butyrate were 40.08, 15.41 and 9.78 mmol/L, respectively.
a, b Within a row, means without a common superscript differ (P < 0.05).